Investors

Press Release

<< Back
Synta to Present at the Roth Capital Partners 24th Annual OC Growth Stock Conference

Company to Webcast Presentation on March 13

LEXINGTON, Mass.--(BUSINESS WIRE)--Mar. 6, 2012-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the Roth Capital Partners 24th Annual OC Growth Stock Conference on Tuesday, March 13 at 11:00 a.m. (PT) / 2:00 p.m. (ET) in Laguna Niguel, California.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, www.syntapharma.com.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.

Source: Synta Pharmaceuticals Corp.

Synta Pharmaceuticals Corp.
Rob Kloppenburg, 781-541-7125